Well if the final trial data is just as strong as the previous news releases hinted at and assuming they stay on track for submission and approval in the U.S., the stock could/should go up significantly. Hopefully the company shares the final trial data soon while they work on setting up a meeting with the FDA. They do need to raise cash somehow, so that's still a hurdle to get over.
News 
Market Data 
Discover 
AI
